ARCHIVES

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

This article is from The Cancer Letter archive.

Vol. 21 No. 42 | November 3, 1995

Download PDF Visit The Full Archive

Related Articles

FDA seeks support for reorganization of cancer programs, but debate continues.

July 9, 2004

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986

More Minorities, Women, Fewer MD On Study Sections

September 2, 1988

Text of PDQ Statement on Breast Screening

September 17, 1993

In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES

August 3, 1979

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007